Update on Joint Oncology Drug Review (JODR) (NOPS 2009)

By Mona Sabharwal, Senior Manager, Drug Benefits Management, Ontario Public Drug Programs, Ministry of Health and Long Term Care, Toronto, ON

Objectives:

• Understand the rationale for this national collaborative initiative
• Describe the evaluative framework for reviewing new drug therapies / indications under the interim JODR process
• Become familiar with the key principles that will form the foundation of the permanent JODR process
• Conceptualize the impact the permanent JODR process may have on future drug funding